Here's Why Investors Should Retain Werner (WERN) Stock Now
https://www.zacks.com/stock/news/2325159/here-s-why-investors-should-retain-werner-wern-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2325159
Aug 21, 2024 - Werner's (WERN) bottom line is bolstered by falling operating expenses. Shareholder-friendly actions also bode well. However, the company's top line is grappling with weak freight demand.
0
Here's Why Investors Should Avoid Old Domain (ODFL) Stock Now
https://www.zacks.com/stock/news/2325122/here-s-why-investors-should-avoid-old-domain-odfl-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2325122
Aug 21, 2024 - Old Domain (ODFL) is grappling with elevated operating costs. Weakness in the economy also does not bode well for the company.
0
1 Growth Stock Down 50% to Buy Right Now
https://www.fool.com/investing/2024/08/21/1-growth-stock-down-50-to-buy-right-now/?source=iedfolrf0000001
Aug 21, 2024 - Disney is trading at a bargain right now, and you don't want to miss out.
0
Reasons to Retain Insperity (NSP) Stock in Your Portfolio Now
https://www.zacks.com/stock/news/2325226/reasons-to-retain-insperity-nsp-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2325226
Aug 21, 2024 - Insperity (NSP) relies on its diversified revenue base to mitigate market risks.
0
Reasons to Add Cintas (CTAS) Stock to Your Portfolio Now
https://www.zacks.com/stock/news/2325086/reasons-to-add-cintas-ctas-stock-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2325086
Aug 21, 2024 - Cintas (CTAS) is set to gain from strength across its businesses, acquired assets and shareholder-friendly policies.
0
This Rising Biotech Is a Fantastic Weight-Loss Stock to Buy Now
https://www.fool.com/investing/2024/08/21/this-rising-biotech-a-fantastic-weight-loss-stock/?source=iedfolrf0000001
Aug 21, 2024 - Its pipeline is one of the best among weight loss-focused biotechs right now.
0
AEON Biopharma, Inc. (AEON) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
https://www.zacks.com/stock/news/2325020/aeon-biopharma-inc-aeon-may-find-a-bottom-soon-here-s-why-you-should-buy-the-stock-now?cid=CS-ZC-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2325020
Aug 21, 2024 - AEON Biopharma, Inc. (AEON) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
0
Are Investors Undervaluing Monarch Casino & Resort (MCRI) Right Now?
https://www.zacks.com/stock/news/2324939/are-investors-undervaluing-monarch-casino-resort-mcri-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2324939
Aug 21, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
Are Investors Undervaluing CrossAmerica Partners (CAPL) Right Now?
https://www.zacks.com/stock/news/2324941/are-investors-undervaluing-crossamerica-partners-capl-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2324941
Aug 21, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
Are Investors Undervaluing Royal Caribbean Cruises (RCL) Right Now?
https://www.zacks.com/stock/news/2324938/are-investors-undervaluing-royal-caribbean-cruises-rcl-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2324938
Aug 21, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0